Skip to main content

Advertisement

Log in

Hepatocellular carcinoma

Low risk of HCC in patients who have PSC and cirrhosis

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

Primary sclerosing cholangitis (PSC) is understood to be associated with an increased risk of malignancy in the bile ducts, gallbladder and colon. The risk of hepatocellular carcinoma in the setting of PSC, however, is not well defined. Zenouzi et al. provide an analysis of their experience in a recent article

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Classic 'onion skin' fibrosis, causing obliteration of the bile ducts in primary sclerosing cholangitis.

References

  1. Zenouzi, R. et al. Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis. Clin. Gastroenterol. Hepatol. http://dx.doi.org/10.1016/j.cgh.2014.02.008.

  2. El-Serag, H. B. Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118–1127 (2011).

    Article  CAS  Google Scholar 

  3. Harnois, D. M. et al. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J. Hepatol. 27, 512–516 (1997).

    Article  CAS  Google Scholar 

  4. Hytiroglou, P. et al. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology 21, 703–708 (1995).

    CAS  PubMed  Google Scholar 

  5. Mion, F., Grozel, L., Boillot, O., Paliard, P. & Berger, F. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 111, 1587–1592 (1996).

    Article  CAS  Google Scholar 

  6. Goss, J. A. et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann. Surg. 225, 472–481 (1997).

    Article  CAS  Google Scholar 

  7. Tischendorf, J. J., Hecker, H., Kruger, M., Manns, M. P. & Meier, P. N. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am. J. Gastroenterol. 102, 107–114 (2007).

    Article  Google Scholar 

  8. Burak, K. et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am. J. Gastroenterol. 99, 523–526 (2004).

    Article  Google Scholar 

  9. Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J. & Lindor, K. D. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 145, 521–536 (2013).

    Article  CAS  Google Scholar 

  10. Razumilava, N., Gores, G. J. & Lindor, K. D. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54, 1842–1852 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keith D. Lindor.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gossard, A., Lindor, K. Low risk of HCC in patients who have PSC and cirrhosis. Nat Rev Gastroenterol Hepatol 11, 276–277 (2014). https://doi.org/10.1038/nrgastro.2014.47

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2014.47

  • Springer Nature Limited

This article is cited by

Navigation